JASON BERLIN: Open Payments
NPI 1841929247 · HALIFAX, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,386 in 144 payments from 26 companies in 2025. Trend: 2023 $2,222 · 2024 $2,891 · 2025 $3,386
Food & beverage: $3,386
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $808 |
| Novo Nordisk Inc | 18 | $447 |
| ABBVIE INC. | 18 | $414 |
| PFIZER INC. | 20 | $302 |
| Otsuka America Pharmaceutical, Inc. | 12 | $212 |
| Lilly USA, LLC | 10 | $190 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $164 |
| Dexcom, Inc. | 3 | $139 |
| Axsome Therapeutics, Inc. | 4 | $80 |
| Phathom Pharmaceuticals, Inc. | 5 | $72 |
Products named: AIRSUPRA, BREZTRI, Ozempic, QULIPTA, REXULTI, JARDIANCE, ELIQUIS, Wegovy.
Industry payments across PA — which companies pay providers there.
